🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The most non consensus thing in crypto over the past year was to bet on ex FTX people. With the benefit of hindsight, it’s starting to be clear that this was one of the most obviously correct things to do.

After almost 16 months, I've managed to recover ~80% of my FTX loss finally. I didn't want to struggle with painful creditor emails, scams, KYCs, etc. anymore. I just got tired of it. Of course, I could wait another year and eventually receive 100% or even more, but as far as

The Goated Beta is LIVE 🐐 Welcome to the future of speculation at Goated.com Get your bankroll ready and start earning points.

We’re thrilled to announce that we’ve raised an Angel Round from some of the leading figures in Web 3: Sandeep | CEO, Polygon Foundation (※,※), 0xMaki, thiccy, degentrading, @gajeshnaik, Roger GAMBLE, Joe Takayama🎒, R🐽ter, Sukhans, Andreas, victor, Zion, and many more.

We announced OpenAI o1 just 3 months ago. Today, we announced o3. We have every reason to believe this trajectory will continue.

Excited to announce that we raised our Series A for @Slingshotai_inc, led by a16z to help advance our mission of using AI to help scale access to mental health care.

Hyperliquid, Farcaster and others feel consumer-grade applications because of Privy.

The way we develop new drugs is broken. The process costs too much, takes too long, and far too often it simply doesn't work. I sat down with five leaders in the field—from industry, VC, academia, and government—to hear their takes on how, and why, and what we can do about it.

For the first episode of Development & Research, I spoke with Meri Beckwith on: • being a patient in an incompetently-run clinical trial, • how many drug trials fail b/c of bad paperwork, • who benefits when trials are expensive, • just how quickly biotech founders lose